Response to: ’Sequential tofacitinib and low-dose interleukin-2 therapy: reassessing biomarkers and mechanistic gaps in alopecia areata’ | Li Lab

Jundong Huang and Wei Shi

doi:10.1093/qjmed/hcaf250

Abstract

An abstract is not currently available here. Please see the publisher’s article.

← Back to publications